Allurion Technologies Inc. (ALUR)

USD 0.31

(-1.65%)

Operating Expenses Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual operating expenses in 2023 was 120.57 Million USD , up 44.07% from previous year.
  • Allurion Technologies Inc.'s latest quarterly operating expenses in 2024 Q1 was 17.99 Million USD , down -43.9% from previous quarter.
  • Allurion Technologies Inc. reported a annual operating expenses of 82.73 Million USD in annual operating expenses 2022, up 98.45% from previous year.
  • Allurion Technologies Inc. reported a annual operating expenses of 41.69 Million USD in annual operating expenses 2021, up 806302.32% from previous year.
  • Allurion Technologies Inc. reported a quarterly operating expenses of 18.15 Million USD for 2024 Q2, up 0.91% from previous quarter.
  • Allurion Technologies Inc. reported a quarterly operating expenses of 40.12 Million USD for 2023 Q3, up 72.48% from previous quarter.

Annual Operating Expenses Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Operating Expenses of Allurion Technologies Inc. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 120.57 Million USD 44.07%
2022 82.73 Million USD 98.45%
2021 41.69 Million USD 806302.32%
2020 5170.00 USD 0.0%

Peer Operating Expenses Comparison of Allurion Technologies Inc.

Name Operating Expenses Operating Expenses Difference
Abbott Laboratories 15.71 Billion USD 99.233%
Artivion, Inc. 223.43 Million USD 46.036%
Avanos Medical, Inc. 375.5 Million USD 67.889%
Butterfly Network, Inc. 162.46 Million USD 25.784%
Butterfly Network, Inc. 162.46 Million USD 25.784%
Bio-Rad Laboratories, Inc. 1.04 Billion USD 88.49%
Boston Scientific Corporation 7.47 Billion USD 98.388%
Perspective Therapeutics, Inc. 17.42 Million USD -591.926%
CONMED Corporation 564.24 Million USD 78.631%
Edwards Lifesciences Corporation 3.09 Billion USD 96.099%
Paragon 28, Inc. 210.1 Million USD 42.611%
Glaukos Corporation 367.83 Million USD 67.22%
Globus Medical, Inc. 887.16 Million USD 86.409%
Inspire Medical Systems, Inc. 568.49 Million USD 78.79%
Integer Holdings Corporation 250.95 Million USD 51.954%
Medtronic plc 16.12 Billion USD 99.252%
Nevro Corp. 389.36 Million USD 69.033%
Owlet, Inc. 51.21 Million USD -135.411%
Penumbra, Inc. 590.87 Million USD 79.594%
Vicarious Surgical Inc. 80.66 Million USD -49.474%
Smith & Nephew plc 3.46 Billion USD 96.522%
Sonendo, Inc. 68.46 Million USD -76.112%
STERIS plc 1.4 Billion USD 91.39%
Stryker Corporation 9.2 Billion USD 98.691%
Vapotherm, Inc. 66.02 Million USD -82.62%
Zimmer Biomet Holdings, Inc. 3.27 Billion USD 96.319%